Bakels V, Van Oostveen J W, Geerts M L, Gordijn R L, Walboomers J M, Scheffer E, Meijer C J, Willemze R
Department of Dermatology, Free University Hospital, Amsterdam, The Netherlands.
J Pathol. 1993 Jul;170(3):249-55. doi: 10.1002/path.1711700306.
In this study, 25 involved and uninvolved lymph nodes from 22 patients with mycosis fungoides (MF) and seven dermatopathic lymph nodes from patients with benign skin disorders were studied for the presence of clonal T-cell receptor beta (TCR beta) gene rearrangements by Southern blot analysis. These results were correlated with the histological classification, follow-up data, and survival. The results of the histological classification and Southern blot analysis were concordant in 26 of 32 cases. Clonal TCR beta gene rearrangements were found in all six MF lymph nodes showing (partial) effacement of the normal lymph node architecture, but in none of the eight uninvolved dermatopathic MF lymph nodes and in none of the seven dermatopathic control lymph nodes. In addition, in 5 of 11 dermatopathic MF lymph nodes that were considered to have early involvement by MF at histological examination, clonal TCR beta gene rearrangements were detected. In the group of MF patients with dermatopathic lymphadenopathy, patients with detectable clonal T-cell populations had a significantly shorter survival than patients without such a population (P < 0.01). The results of this study indicate that within the group of dermatopathic MF lymph nodes, prognostically different groups can be distinguished and that TCR beta gene rearrangement analysis may be an important adjunct in the early diagnosis of lymph node involvement by MF.
在本研究中,通过Southern印迹分析,对22例蕈样肉芽肿(MF)患者的25个受累及未受累淋巴结以及良性皮肤疾病患者的7个皮肤病理淋巴结进行了克隆性T细胞受体β(TCRβ)基因重排检测。这些结果与组织学分类、随访数据及生存率相关。组织学分类和Southern印迹分析结果在32例中的26例中一致。在所有6个显示正常淋巴结结构(部分)消失的MF淋巴结中均发现克隆性TCRβ基因重排,但在8个未受累的皮肤病理MF淋巴结及7个皮肤病理对照淋巴结中均未发现。此外,在组织学检查认为有MF早期受累的11个皮肤病理MF淋巴结中的5个中检测到克隆性TCRβ基因重排。在有皮肤病理淋巴结病的MF患者组中,检测到克隆性T细胞群体的患者生存率明显低于无此群体的患者(P<0.01)。本研究结果表明,在皮肤病理MF淋巴结组中,可以区分出预后不同的组,并且TCRβ基因重排分析可能是MF淋巴结受累早期诊断的重要辅助手段。